Display Settings:

Format

Send to:

Choose Destination
Infection. 2013 Feb;41(1):225-9. doi: 10.1007/s15010-012-0305-y. Epub 2012 Aug 2.

Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma.

Author information

  • 1Department of Public Medicine, Section of Infectious Diseases, Second University of Naples, Via L. Armanni 5, 80131, Naples, Italy.

Abstract

A female patient with non-Hodgkin lymphoma who tested positive for surface antigen of the hepatitis B virus and negative for hepatitis B core antibody experienced a reactivation of occult HBV infection 20 months after rituximab discontinuation despite lamivudine prophylaxis covering the 4 months of rituximab administration and the subsequent 12 months.

PMID:
22855434
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk